Physician profile
Andrea Yonge
NPI 1144644543
$4,022.93
in general payments reported to CMS, 2019-2025
11 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $722 · 2021: $640 · 2022: $821 · 2023: $442 · 2024: $1,109 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,839.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,279.22 | 2019-2024 | Hydrus Microstent, Rocklatan, Clareon |
| Abbvie INC. | $948.38 | 2022-2025 | Xen Glaucoma Treatment System |
| Allergan, INC. | $635.15 | 2021-2022 | |
| Rxsight INC | $401.91 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Johnson & Johnson Surgical Vision, INC. | $245.19 | 2023-2024 | Tecnis Iol, Amo Phaco Needle, Tecnis Iol |
| Sight Sciences, INC. | $205.67 | 2022-2024 | Omni Surgical System |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2019 | |
| Aerie Pharmaceuticals, INC. | $110.09 | 2021 | |
| Ivantis, INC | $36.66 | 2021 | |
| Glaukos Corporation | $19.84 | 2025 | Istent Infinite |
| New World Medical,INC. | $15.82 | 2024 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Yonge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.